GI
MBOT icon

Gradient Investments’s Microbot Medical MBOT Stock Holding History

Gradient Investments’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,000
Closed -$11K – 1173
2019
Q3 		$11K Buy
+2,000
New +$11.7K ﹤0.01% 644
2014
Q1 		– Hold
0
– – – 587
2013
Q4 		– Hold
0
– – – 624

Other funds holding MBOT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Gradient Investments's MBOT Position: Q4 2019 in Review

Gradient Investments sold out of Microbot Medical (MBOT) in Q4 2019, closing a stake of 2,000 shares — an estimated $11K sold.

Gradient Investments first reported a position in MBOT in Q3 2019 and held it in 1 quarter. The position peaked at $11K in Q3 2019. 28 funds tracked by Wall St. Rank hold MBOT as of Q4 2019.

  • Gradient Investments reported no remaining Microbot Medical position as of Q4 2019 after selling out during the quarter.
  • Gradient Investments sold 2,000 Microbot Medical shares in Q4 2019, an estimated $11K.
  • Gradient Investments first reported a position in Microbot Medical in Q3 2019 and held it in 1 quarter.
  • Gradient Investments's Microbot Medical position peaked at $11K in Q3 2019.
  • 28 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2019.

Based on Gradient Investments's 13F filing for Q4 2019, filed 15 Jan 2020.